These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 20863155

  • 1. The significance of detecting WT1 expression in childhood acute leukemias.
    Hu SY, Gu WY, Chen ZX, Wang XL, Cen JN, He HL, Chai YH, Chen CS.
    Pediatr Hematol Oncol; 2010 Nov; 27(8):581-91. PubMed ID: 20863155
    [Abstract] [Full Text] [Related]

  • 2. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L, Kalinova M, Ryan J, Quinn F, O'Marcaigh A, Smith O, Browne P, Stary J, McCann SR, Trka J, Lawler M.
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [Abstract] [Full Text] [Related]

  • 3. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
    Uzunel M, Ringdén O.
    Bone Marrow Transplant; 2004 Jan; 33(1):47-52. PubMed ID: 14704656
    [Abstract] [Full Text] [Related]

  • 4. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
    Zhang R, Yang JY, Sun HQ, Jia H, Liao J, Shi YJ, Li G.
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(14):2679-88. PubMed ID: 26221900
    [Abstract] [Full Text] [Related]

  • 5. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY, Chen ZX, Hu SY, Zhu J, Wang ZL, Yan F, Wang W, Cen JN, Shen HL, Qian J.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):444-7. PubMed ID: 15854547
    [Abstract] [Full Text] [Related]

  • 6. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.
    Candoni A, Toffoletti E, Gallina R, Simeone E, Chiozzotto M, Volpetti S, Fanin R.
    Clin Transplant; 2011 Feb 23; 25(2):308-16. PubMed ID: 20412098
    [Abstract] [Full Text] [Related]

  • 7. Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia.
    Spanaki A, Linardakis E, Perdikogianni C, Stiakaki E, Morotti A, Cilloni D, Kalmanti M.
    Leuk Res; 2007 Apr 23; 31(4):570-2. PubMed ID: 16876863
    [Abstract] [Full Text] [Related]

  • 8. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
    Qin Y, Zhu H, Jiang B, Li J, Lu X, Li L, Ruan G, Liu Y, Chen S, Huang X.
    Leuk Res; 2009 Mar 23; 33(3):384-90. PubMed ID: 18950857
    [Abstract] [Full Text] [Related]

  • 9. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
    Candoni A, Tiribelli M, Toffoletti E, Cilloni D, Chiarvesio A, Michelutti A, Simeone E, Pipan C, Saglio G, Fanin R.
    Eur J Haematol; 2009 Jan 23; 82(1):61-8. PubMed ID: 18801058
    [Abstract] [Full Text] [Related]

  • 10. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M, Palasek I, Pospisil Z, Borsky M, Klabusay M, Brychtova Y, Jurcek T, Jeziskova I, Krejci M, Dvorakova D, Mayer J.
    Exp Hematol; 2009 Jun 23; 37(6):659-72. PubMed ID: 19463768
    [Abstract] [Full Text] [Related]

  • 11. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
    Magyarosy E, Varga N, Timár J, Rásó E.
    Pediatr Hematol Oncol; 2003 Jun 23; 20(1):65-74. PubMed ID: 12687755
    [Abstract] [Full Text] [Related]

  • 12. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM, Kairisto V, Juvonen V, Johansson J, Aurén J, Kohonen K, Remes K, Salmi TT, Helenius H, Pelliniemi TT.
    Eur J Haematol; 2008 Mar 23; 80(3):201-7. PubMed ID: 18081724
    [Abstract] [Full Text] [Related]

  • 13. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
    Chen JS, Hsiao CC, Sheen JM, Cheng CN.
    Leuk Res; 2007 Oct 23; 31(10):1351-7. PubMed ID: 17445885
    [Abstract] [Full Text] [Related]

  • 14. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
    Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss T, Izzo B, Nomdedeu J, van der Heijden A, van der Reijden BA, Jansen JH, van der Velden VH, Ommen H, Preudhomme C, Saglio G, Grimwade D.
    J Clin Oncol; 2009 Nov 01; 27(31):5195-201. PubMed ID: 19752335
    [Abstract] [Full Text] [Related]

  • 15. Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets.
    Rossi G, Minervini MM, Carella AM, de Waure C, di Nardo F, Melillo L, D'Arena G, Zini G, Cascavilla N.
    Leuk Res; 2012 Apr 01; 36(4):401-6. PubMed ID: 22196957
    [Abstract] [Full Text] [Related]

  • 16. [Detection of WT1 expression in bone marrow of acute leukemia patients with real-time quantitative RT-PCR].
    Gu WY, Chen ZX, Cao XS, Hu SY, Zhu J, Wang ZL, Yan F, Wang W, Cen JN, Shen HL, Qian J.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec 01; 25(12):728-31. PubMed ID: 15730716
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
    Kwon M, Martínez-Laperche C, Infante M, Carretero F, Balsalobre P, Serrano D, Gayoso J, Pérez-Corral A, Anguita J, Díez-Martín JL, Buño I.
    Biol Blood Marrow Transplant; 2012 Aug 01; 18(8):1235-42. PubMed ID: 22281301
    [Abstract] [Full Text] [Related]

  • 18. WT1 protein expression in childhood acute leukemia.
    Kerst G, Bergold N, Gieseke F, Coustan-Smith E, Lang P, Kalinova M, Handgretinger R, Trka J, Müller I.
    Am J Hematol; 2008 May 01; 83(5):382-6. PubMed ID: 18161786
    [Abstract] [Full Text] [Related]

  • 19. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
    Lapillonne H, Renneville A, Auvrignon A, Flamant C, Blaise A, Perot C, Lai JL, Ballerini P, Mazingue F, Fasola S, Dehée A, Bellman F, Adam M, Labopin M, Douay L, Leverger G, Preudhomme C, Landman-Parker J.
    J Clin Oncol; 2006 Apr 01; 24(10):1507-15. PubMed ID: 16575000
    [Abstract] [Full Text] [Related]

  • 20. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
    Siehl JM, Reinwald M, Heufelder K, Menssen HD, Keilholz U, Thiel E.
    Ann Hematol; 2004 Dec 01; 83(12):745-50. PubMed ID: 15340762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.